Less Than First: Below-Average Innovation In US FDA’s Big 2023 Novel Approval Haul

 
• By Bridget Silverman
below average
The US FDA approval class of did not get strong marks in some areas. • Source: Shutterstock

More from Approvals

More from Product Reviews